342 related articles for article (PubMed ID: 24141505)
21. Classification and diagnostic criteria for demyelinating diseases of the central nervous system: Where do we stand today?
Mathey G; Michaud M; Pittion-Vouyovitch S; Debouverie M
Rev Neurol (Paris); 2018 Jun; 174(6):378-390. PubMed ID: 29673575
[TBL] [Abstract][Full Text] [Related]
22. [Diagnostic criteria in acute neuromyelitis].
Panea C; Petrescu S; Monica P; Voinea L; Dascălu AM; Nicolae M; Ungureanu E; Panca A; Grădinaru S
Oftalmologia; 2007; 51(4):116-20. PubMed ID: 18543687
[TBL] [Abstract][Full Text] [Related]
23. Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders.
Kira J
J Neurol Sci; 2011 Dec; 311(1-2):69-77. PubMed ID: 21962794
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic modalities in multiple sclerosis: perspectives in children.
Chou IJ; Whitehouse WP; Wang HS; Tanasescu R; Constantinescu CS
Biomed J; 2014; 37(2):50-9. PubMed ID: 24732659
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology, immunopathogenesis and management of pediatric central nervous system inflammatory demyelinating conditions.
Pohl D
Curr Opin Neurol; 2008 Jun; 21(3):366-72. PubMed ID: 18451724
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis and Management of Central Nervous System Demyelinating Disorders.
Touma L; Muccilli A
Neurol Clin; 2022 Feb; 40(1):113-131. PubMed ID: 34798965
[TBL] [Abstract][Full Text] [Related]
27. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome.
Hennes EM; Baumann M; Schanda K; Anlar B; Bajer-Kornek B; Blaschek A; Brantner-Inthaler S; Diepold K; Eisenkölbl A; Gotwald T; Kuchukhidze G; Gruber-Sedlmayr U; Häusler M; Höftberger R; Karenfort M; Klein A; Koch J; Kraus V; Lechner C; Leiz S; Leypoldt F; Mader S; Marquard K; Poggenburg I; Pohl D; Pritsch M; Raucherzauner M; Schimmel M; Thiels C; Tibussek D; Vieker S; Zeches C; Berger T; Reindl M; Rostásy K;
Neurology; 2017 Aug; 89(9):900-908. PubMed ID: 28768844
[TBL] [Abstract][Full Text] [Related]
28. Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese.
Chan KH; Lee R; Lee JC; Tse AC; Pang SY; Lau GK; Teo KC; Ho PW
J Neuroimmunol; 2013 Sep; 262(1-2):100-5. PubMed ID: 23838529
[TBL] [Abstract][Full Text] [Related]
29. Acute disseminated encephalomyelitis or multiple sclerosis: can the initial presentation help in establishing a correct diagnosis?
Dale RC; Branson JA
Arch Dis Child; 2005 Jun; 90(6):636-9. PubMed ID: 15908633
[TBL] [Abstract][Full Text] [Related]
30. The limited demyelinating diseases: the voyage of optic neuritis and transverse myelitis to multiple sclerosis and neuromyelitis.
Idiman E; Ozakbaş S
Expert Rev Neurother; 2011 Mar; 11(3):451-62. PubMed ID: 21375450
[TBL] [Abstract][Full Text] [Related]
31. Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report.
Chitnis T; Ness J; Krupp L; Waubant E; Hunt T; Olsen CS; Rodriguez M; Lotze T; Gorman M; Benson L; Belman A; Weinstock-Guttman B; Aaen G; Graves J; Patterson M; Rose JW; Casper TC
Neurology; 2016 Jan; 86(3):245-52. PubMed ID: 26683648
[TBL] [Abstract][Full Text] [Related]
32. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.
Banwell B; Tenembaum S; Lennon VA; Ursell E; Kennedy J; Bar-Or A; Weinshenker BG; Lucchinetti CF; Pittock SJ
Neurology; 2008 Jan; 70(5):344-52. PubMed ID: 18094334
[TBL] [Abstract][Full Text] [Related]
33. Multiple sclerosis, acute disseminated encephalomyelitis, and related conditions.
Rust RS
Semin Pediatr Neurol; 2000 Jun; 7(2):66-90. PubMed ID: 10914409
[TBL] [Abstract][Full Text] [Related]
34. Immune-mediated CNS diseases: a review on nosological classification and clinical features.
Zettl UK; Stüve O; Patejdl R
Autoimmun Rev; 2012 Jan; 11(3):167-73. PubMed ID: 21619943
[TBL] [Abstract][Full Text] [Related]
35. Bibliography. Current world literature. Demyelinating diseases.
Curr Opin Neurol; 2007 Jun; 20(3):358-67. PubMed ID: 17495633
[No Abstract] [Full Text] [Related]
36. Detection of autoantibodies against NMDA-type glutamate receptor in a patient with recurrent optic neuritis and transient cerebral lesions.
Ishikawa N; Tajima G; Hyodo S; Takahashi Y; Kobayashi M
Neuropediatrics; 2007 Oct; 38(5):257-60. PubMed ID: 18330842
[TBL] [Abstract][Full Text] [Related]
37. [An interpretation of consensus statements on diagnostic criteria for multiple sclerosis and demyelinating diseases of the central nervous system in children (2012 version)].
Yang KF; Chen YC
Zhongguo Dang Dai Er Ke Za Zhi; 2016 Dec; 18(12):1199-1204. PubMed ID: 27974107
[TBL] [Abstract][Full Text] [Related]
38. Back on the scent: the olfactory system in CNS demyelinating diseases.
Joseph A; DeLuca GC
J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1146-54. PubMed ID: 27003274
[TBL] [Abstract][Full Text] [Related]
39. Paediatric Multiple Sclerosis: Update on Diagnostic Criteria, Imaging, Histopathology and Treatment Choices.
Chou IJ; Wang HS; Whitehouse WP; Constantinescu CS
Curr Neurol Neurosci Rep; 2016 Jul; 16(7):68. PubMed ID: 27271748
[TBL] [Abstract][Full Text] [Related]
40. Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica.
Jiang Y; Yang Y; Zhang B; Peng F; Bao J; Hu X
Neuro Endocrinol Lett; 2009 Mar; 30(1):85-90. PubMed ID: 19300400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
